|Bid||0.00 x 1200|
|Ask||50.00 x 800|
|Day's Range||48.61 - 49.17|
|52 Week Range||42.17 - 75.75|
|Beta (3Y Monthly)||1.42|
|PE Ratio (TTM)||20.84|
|Earnings Date||Feb 7, 2019|
|Forward Dividend & Yield||1.91 (3.96%)|
|1y Target Est||53.86|
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
# Cardinal Health Inc ### NYSE:CAH View full report here! ## Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is low for CAH with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $14.67 billion over the last one-month into ETFs that hold CAH are among the highest of the last year, but the rate of growth is slowing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. ## Credit worthiness Credit default swap | Negative The current level displays a negative indicator. CAH credit default swap spreads are at their highest levels for the past 3 years, which indicates the market's more negative perception of the company's credit worthiness. Please send all inquiries related to the report to email@example.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
DUBLIN, Ohio , Jan. 14, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2019 on February 7 prior to the opening of trading on the ...
The municipalities allege that the companies misled health care providers about addiction risks of opioids, leading to abuse of opioids in their communities.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more Read More...
Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS
The task of designing one's portfolio to include potential outperformers is not an easy one. Broker advice is necessary to design a winning portfolio.
Let's see if Cardinal Health, Inc. (CAH) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
According to the GuruFocus All-In-One Screener, the following health care stocks are popular among guru investors. Warning! GuruFocus has detected 2 Warning Sign with CAH. The company, which provides services and products for hospital systems and physicians' offices, has a market cap of $13.5 billion.
NEW YORK, Dec. 18, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Cardinal Health, Inc. (NYSE:CAH) has pleased shareholders over the past 10 years, by paying out dividends. The company is currently worth US$16b, and now yields roughly 3.6%. Does Cardinal Health Read More...
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth depends on it. Regardless of the various methods used by elite investors like David Tepper and Dan Loeb, […]
Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DUBLIN, Ohio, Dec. 7, 2018 /PRNewswire/ -- Cardinal Health (CAH) today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.
DUBLIN, Ohio, Nov. 30, 2018 /PRNewswire/ -- Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty Solutions. Request a copy of the Oncology Insights report at www.cardinalhealth.com/oncologyinsights. The report compares current views about MACRA to responses collected in early 2017, shortly after MACRA went into effect.
Cardinal Health (CAH) helps hospitals identify hidden savings, improve patient outcomes and drive supply chain efficiencies.
Cardinal Health introduces approach to address sustainable cost control DUBLIN, Ohio , Nov. 27, 2018 /PRNewswire/ -- At the 2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting, ...
The drug distributor is able to turn its significant size and market share into key competitive advantages. Cardinal is an important cog in the pharmaceutical industry, as many supply-chain participants depend on its services for streamlined product distribution and procurement. Cardinal is the third-largest pharmaceutical distributor by revenue and is the main supplier to CVS Health's retail pharmacy network.